Ex Parte Redmond et al - Page 5




                 Appeal No. 2005-2671                                                                                                              
                 Application No. 09/971,774                                                                                                        
                         [i]t would have been obvious to one having ordinary skill in the art at the                                               
                         time the invention was made to administer a solution of taurolidine and/or                                                
                         taurultam (with or without heparin) during laparoscopic abdominal cancer                                                  
                         surgery. MONSON had taught that these species (taurolidine and/or                                                         
                         taurultam) are functional equivalents for the inhibition of metastases. ...  It                                           
                         would have been obvious to one having ordinary skill in the art at the time                                               
                         the invention was made to administer a solution of taurolidine and/or                                                     
                         taurultam before and/or after cancer surgery for the benefits of treating                                                 
                         malignancies as well as prevention of metastases, taught by MONSON. ...                                                   
                         We agree that the examiner has established a prima facie case of obviousness                                              
                 with respect to claim 1.  Jacobi teaches administration of taurolidine during surgery in                                          
                 the form of a postoperative lavage.  Translation, page 9.   Thus, Jacobi teaches the step                                         
                 of “the method including a step of administering taurolidine, taurultam or a mixture                                              
                 thereof to the patient's abdomen prior to said closing of said surgical opening and after                                         
                 said surgically removing said cancerous tumor” as claimed.  Monson clearly suggests                                               
                 the use of taurolidine, especially following the surgical removal of tumors.  Monson,                                             
                 page 3.  Thus, in our view, the examiner has provided sufficient evidence to support a                                            
                 prima facie case of obviousness, including a reason suggestion or motivation to                                                   
                 combine the cited references.                                                                                                     
                         Appellants argue in response that (Brief, page 7)                                                                         
                         There is no suggestion in the applied prior art of the specific steps of the                                              
                         present claims, wherein the tumor is removed, taurolidine and/or taurultam                                                
                         is administered to the abdomen prior to closing of the surgical opening                                                   
                         and after surgical removal of the tumor, and additionally administering                                                   
                         taurolidine and/or taurultam to the patient after closing the surgical                                                    
                         opening.                                                                                                                  
                         With respect to claim 1, we disagree with appellants’ argument.   We agree with                                           
                 the examiner that “Appellants fail to state why the combination of references is invalid.”                                        
                                                                        5                                                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007